Guidance
WHO SAGE roadmap on uses of COVID-19 vaccines in the context of OMICRON and substantial population immunity
An approach to optimize the global impact of COVID-19 vaccines at a time when Omicron and its sub-lineages are the dominant circulating variants of concern, based on public health goals, evolving epidemiology, and increasing population-level immunity
Authors
Languages
- English
Publication year
2020
Type
Guidance
Categories
- Vaccines & delivery devices
Diseases
- COVID-19
Organisations
- World Health Organisation (WHO)
